
Optometrists learn to recognize and manage pediatric dry eye and myopia, emphasizing proactive care and lifestyle changes for better outcomes.
Dr. Tucker is a therapeutic optometrist at the Contact Lens Institute of Houston and Bellaire Family Eye Care in Bellaire, Texas
Optometrists learn to recognize and manage pediatric dry eye and myopia, emphasizing proactive care and lifestyle changes for better outcomes.
In honor of the Myopia Management Navigator’s 1-year anniversary, Dr Tucker shares clinical insights, practical tips, and business opportunities for optometrists looking to expand their scope and elevate patient care through evidence-based myopia management.
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
For Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, last week's conference gives a unique opportunity for optometrists and ophthalmologists to collaborate.
At the Envision Summit 2025 in San Juan, Puerto Rico, Ashley Wallace Tucker, OD, FAAO, FSLS, gave insight into advancements in keratoconus management and the importance of early detection as well as tips and advice on fitting scleral contact lens
From eye drops to novel treatments, it’s time to assess all options for improving patients’ visual acuity.
EnVision Summit optometry faculty Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Currently, there are several novel spectacle designs available across the world. Unfortunately, none of them are available in the US currently.
Although the use of atropine is not necessarily novel in the myopia management world, the fact that practitioners may soon have an FDA approved formulation of atropine is new and exciting.
New research suggests sleep is an additional risk factor affecting myopia onset and progression.
In a sham device-controlled, randomized, double-blind clinical trial in China, researchers utilized a device that emits 650 nm red light directly to the retina.
Several eye conditions may benefit from membrane application.
Although the 20-20-20 rule is still a solid recommendation, recent studies have provided practitioners with more specific recommendations to help potentially prevent the onset and slow the progression of myopia.
Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."
Increasing scleral lens use can benefit a larger patient base.
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on advanced fitting and troubleshooting tips for scleral lenses during the South Carolina Optometric Physicians Association’s annual meeting.
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on amniotic membrane treatment for anterior segment disease during the South Carolina Optometric Physicians Association’s annual meeting.
Published: March 3rd 2023 | Updated:
Published: August 27th 2022 | Updated:
Published: November 15th 2022 | Updated:
Published: August 27th 2022 | Updated:
Published: January 29th 2025 | Updated:
Published: December 19th 2024 | Updated: